Sign in
CompletedPhase 4

The Effect of Dexmedetomidine Infusion Alone Versus the Combination of Dexmedetomidine and Melatonin on Reduction of Post-operative Delirium (POD) After Open Brain Surgeries

Key facts

Who runs it
Ain Shams University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
100 people enrolled
Started
1 Aug 2025
Ended
1 Feb 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Dexmedetomidine (DEX)
  • Melatonin
Record updated
16 March 2026

Who can take part

Age
30 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age: 30 - 60 years
  • Sex: Both sexes
  • Patients with open space occupying lesions or hematoma

Who cannot take part

  • Any form of drug addiction
  • Patients receiving any anti-psychotic medications
  • History of previous brain insult (Ischemic or haemorrhagic infarctions)
  • History of allergy to the medications used in the study
  • Psychiatric disorder
  • Pre-operative dementia
  • History of malignant hyperthermia
  • Refusal of the patient to give written informed consent
  • Patient's suffering from bradycardia
  • Patient's suffering from hypotension

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to illuminate the effect of combination of dexmedetomidine and oral melatonin versus the use of dexmedetomidine infusion alone on the improving of post-operative delirium (POD) on patients undergoing open brain surgeries.

The 2 groups in the trial

  • Control GroupExisting treatment, for comparison

    Dexmedetomidine alone

    Treatment: Dexmedetomidine (DEX)

  • Combination GroupExisting treatment, for comparison

    Combination of Dexmedetomidine \& Melatonin

    Treatment: Dexmedetomidine (DEX) and Melatonin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
16 March 2026